 | • レポートコード：QFJ1-3840 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗痙攣薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射、その他）、用途別市場規模（病院、専門診療所、ホームケア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗痙攣薬の市場動向 ・企業の競争状況、市場シェア ・抗痙攣薬の種類別市場規模と予測2016-2027（経口、注射、その他） ・抗痙攣薬の用途別市場規模と予測2016-2027（病院、専門診療所、ホームケア、その他） ・抗痙攣薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗痙攣薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗痙攣薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗痙攣薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗痙攣薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Hikma Pharmaceuticals、Lannett、Mylan、Nexus Pharmaceuticals、Akorn、Aurobindo Pharma、Daiichi Sankyo、Fresenius Kabi、Shanghai Fosun Pharmaceutical、SunGen Pharma） ・結論 |
One type of antispasmodic is used for smooth muscle contraction, especially in the tubular organs of the gastrointestinal tract. The effect is to prevent cramps in the stomach, intestines or bladder.
Market Analysis and Insights: Global Antispasmodics Drugs Market
The global Antispasmodics Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antispasmodics Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antispasmodics Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antispasmodics Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antispasmodics Drugs market.
Global Antispasmodics Drugs Scope and Market Size
Antispasmodics Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antispasmodics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injectable
Others
Segment by Application
Hospital
Special Clinic
Home Care
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Hikma Pharmaceuticals
Lannett
Mylan
Nexus Pharmaceuticals
Akorn
Aurobindo Pharma
Daiichi Sankyo
Fresenius Kabi
Shanghai Fosun Pharmaceutical
SunGen Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antispasmodics Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injectable
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antispasmodics Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Home Care
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antispasmodics Drugs Market Perspective (2016-2027)
2.2 Antispasmodics Drugs Growth Trends by Regions
2.2.1 Antispasmodics Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antispasmodics Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Antispasmodics Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Antispasmodics Drugs Industry Dynamic
2.3.1 Antispasmodics Drugs Market Trends
2.3.2 Antispasmodics Drugs Market Drivers
2.3.3 Antispasmodics Drugs Market Challenges
2.3.4 Antispasmodics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antispasmodics Drugs Players by Revenue
3.1.1 Global Top Antispasmodics Drugs Players by Revenue (2016-2021)
3.1.2 Global Antispasmodics Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Antispasmodics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antispasmodics Drugs Revenue
3.4 Global Antispasmodics Drugs Market Concentration Ratio
3.4.1 Global Antispasmodics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antispasmodics Drugs Revenue in 2020
3.5 Antispasmodics Drugs Key Players Head office and Area Served
3.6 Key Players Antispasmodics Drugs Product Solution and Service
3.7 Date of Enter into Antispasmodics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antispasmodics Drugs Breakdown Data by Type
4.1 Global Antispasmodics Drugs Historic Market Size by Type (2016-2021)
4.2 Global Antispasmodics Drugs Forecasted Market Size by Type (2022-2027)
5 Antispasmodics Drugs Breakdown Data by Application
5.1 Global Antispasmodics Drugs Historic Market Size by Application (2016-2021)
5.2 Global Antispasmodics Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Antispasmodics Drugs Market Size (2016-2027)
6.2 North America Antispasmodics Drugs Market Size by Type
6.2.1 North America Antispasmodics Drugs Market Size by Type (2016-2021)
6.2.2 North America Antispasmodics Drugs Market Size by Type (2022-2027)
6.2.3 North America Antispasmodics Drugs Market Size by Type (2016-2027)
6.3 North America Antispasmodics Drugs Market Size by Application
6.3.1 North America Antispasmodics Drugs Market Size by Application (2016-2021)
6.3.2 North America Antispasmodics Drugs Market Size by Application (2022-2027)
6.3.3 North America Antispasmodics Drugs Market Size by Application (2016-2027)
6.4 North America Antispasmodics Drugs Market Size by Country
6.4.1 North America Antispasmodics Drugs Market Size by Country (2016-2021)
6.4.2 North America Antispasmodics Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Antispasmodics Drugs Market Size (2016-2027)
7.2 Europe Antispasmodics Drugs Market Size by Type
7.2.1 Europe Antispasmodics Drugs Market Size by Type (2016-2021)
7.2.2 Europe Antispasmodics Drugs Market Size by Type (2022-2027)
7.2.3 Europe Antispasmodics Drugs Market Size by Type (2016-2027)
7.3 Europe Antispasmodics Drugs Market Size by Application
7.3.1 Europe Antispasmodics Drugs Market Size by Application (2016-2021)
7.3.2 Europe Antispasmodics Drugs Market Size by Application (2022-2027)
7.3.3 Europe Antispasmodics Drugs Market Size by Application (2016-2027)
7.4 Europe Antispasmodics Drugs Market Size by Country
7.4.1 Europe Antispasmodics Drugs Market Size by Country (2016-2021)
7.4.2 Europe Antispasmodics Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Antispasmodics Drugs Market Size (2016-2027)
8.2 Asia-Pacific Antispasmodics Drugs Market Size by Type
8.2.1 Asia-Pacific Antispasmodics Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antispasmodics Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antispasmodics Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Antispasmodics Drugs Market Size by Application
8.3.1 Asia-Pacific Antispasmodics Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antispasmodics Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antispasmodics Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Antispasmodics Drugs Market Size by Region
8.4.1 Asia-Pacific Antispasmodics Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antispasmodics Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antispasmodics Drugs Market Size (2016-2027)
9.2 Latin America Antispasmodics Drugs Market Size by Type
9.2.1 Latin America Antispasmodics Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Antispasmodics Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Antispasmodics Drugs Market Size by Type (2016-2027)
9.3 Latin America Antispasmodics Drugs Market Size by Application
9.3.1 Latin America Antispasmodics Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Antispasmodics Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Antispasmodics Drugs Market Size by Application (2016-2027)
9.4 Latin America Antispasmodics Drugs Market Size by Country
9.4.1 Latin America Antispasmodics Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Antispasmodics Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antispasmodics Drugs Market Size (2016-2027)
10.2 Middle East & Africa Antispasmodics Drugs Market Size by Type
10.2.1 Middle East & Africa Antispasmodics Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antispasmodics Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antispasmodics Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Antispasmodics Drugs Market Size by Application
10.3.1 Middle East & Africa Antispasmodics Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antispasmodics Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antispasmodics Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Antispasmodics Drugs Market Size by Country
10.4.1 Middle East & Africa Antispasmodics Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antispasmodics Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Antispasmodics Drugs Introduction
11.1.4 Allergan Revenue in Antispasmodics Drugs Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Hikma Pharmaceuticals
11.2.1 Hikma Pharmaceuticals Company Details
11.2.2 Hikma Pharmaceuticals Business Overview
11.2.3 Hikma Pharmaceuticals Antispasmodics Drugs Introduction
11.2.4 Hikma Pharmaceuticals Revenue in Antispasmodics Drugs Business (2016-2021)
11.2.5 Hikma Pharmaceuticals Recent Development
11.3 Lannett
11.3.1 Lannett Company Details
11.3.2 Lannett Business Overview
11.3.3 Lannett Antispasmodics Drugs Introduction
11.3.4 Lannett Revenue in Antispasmodics Drugs Business (2016-2021)
11.3.5 Lannett Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Antispasmodics Drugs Introduction
11.4.4 Mylan Revenue in Antispasmodics Drugs Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Nexus Pharmaceuticals
11.5.1 Nexus Pharmaceuticals Company Details
11.5.2 Nexus Pharmaceuticals Business Overview
11.5.3 Nexus Pharmaceuticals Antispasmodics Drugs Introduction
11.5.4 Nexus Pharmaceuticals Revenue in Antispasmodics Drugs Business (2016-2021)
11.5.5 Nexus Pharmaceuticals Recent Development
11.6 Akorn
11.6.1 Akorn Company Details
11.6.2 Akorn Business Overview
11.6.3 Akorn Antispasmodics Drugs Introduction
11.6.4 Akorn Revenue in Antispasmodics Drugs Business (2016-2021)
11.6.5 Akorn Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Antispasmodics Drugs Introduction
11.7.4 Aurobindo Pharma Revenue in Antispasmodics Drugs Business (2016-2021)
11.7.5 Aurobindo Pharma Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Details
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Antispasmodics Drugs Introduction
11.8.4 Daiichi Sankyo Revenue in Antispasmodics Drugs Business (2016-2021)
11.8.5 Daiichi Sankyo Recent Development
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Company Details
11.9.2 Fresenius Kabi Business Overview
11.9.3 Fresenius Kabi Antispasmodics Drugs Introduction
11.9.4 Fresenius Kabi Revenue in Antispasmodics Drugs Business (2016-2021)
11.9.5 Fresenius Kabi Recent Development
11.10 Shanghai Fosun Pharmaceutical
11.10.1 Shanghai Fosun Pharmaceutical Company Details
11.10.2 Shanghai Fosun Pharmaceutical Business Overview
11.10.3 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Introduction
11.10.4 Shanghai Fosun Pharmaceutical Revenue in Antispasmodics Drugs Business (2016-2021)
11.10.5 Shanghai Fosun Pharmaceutical Recent Development
11.11 SunGen Pharma
11.11.1 SunGen Pharma Company Details
11.11.2 SunGen Pharma Business Overview
11.11.3 SunGen Pharma Antispasmodics Drugs Introduction
11.11.4 SunGen Pharma Revenue in Antispasmodics Drugs Business (2016-2021)
11.11.5 SunGen Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Antispasmodics Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Key Players of Others
Table 5. Global Antispasmodics Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Antispasmodics Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antispasmodics Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Antispasmodics Drugs Market Share by Regions (2016-2021)
Table 9. Global Antispasmodics Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Antispasmodics Drugs Market Share by Regions (2022-2027)
Table 11. Antispasmodics Drugs Market Trends
Table 12. Antispasmodics Drugs Market Drivers
Table 13. Antispasmodics Drugs Market Challenges
Table 14. Antispasmodics Drugs Market Restraints
Table 15. Global Antispasmodics Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Antispasmodics Drugs Market Share by Players (2016-2021)
Table 17. Global Top Antispasmodics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antispasmodics Drugs as of 2020)
Table 18. Ranking of Global Top Antispasmodics Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Antispasmodics Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antispasmodics Drugs Product Solution and Service
Table 22. Date of Enter into Antispasmodics Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Antispasmodics Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Antispasmodics Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Antispasmodics Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Antispasmodics Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Antispasmodics Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Antispasmodics Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Antispasmodics Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Antispasmodics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Antispasmodics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Antispasmodics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Antispasmodics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antispasmodics Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Antispasmodics Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Antispasmodics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Antispasmodics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antispasmodics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Antispasmodics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Antispasmodics Drugs Product
Table 65. Allergan Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Hikma Pharmaceuticals Company Details
Table 68. Hikma Pharmaceuticals Business Overview
Table 69. Hikma Pharmaceuticals Antispasmodics Drugs Product
Table 70. Hikma Pharmaceuticals Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 71. Hikma Pharmaceuticals Recent Development
Table 72. Lannett Company Details
Table 73. Lannett Business Overview
Table 74. Lannett Antispasmodics Drugs Product
Table 75. Lannett Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 76. Lannett Recent Development
Table 77. Mylan Company Details
Table 78. Mylan Business Overview
Table 79. Mylan Antispasmodics Drugs Product
Table 80. Mylan Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Nexus Pharmaceuticals Company Details
Table 83. Nexus Pharmaceuticals Business Overview
Table 84. Nexus Pharmaceuticals Antispasmodics Drugs Product
Table 85. Nexus Pharmaceuticals Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 86. Nexus Pharmaceuticals Recent Development
Table 87. Akorn Company Details
Table 88. Akorn Business Overview
Table 89. Akorn Antispasmodics Drugs Product
Table 90. Akorn Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 91. Akorn Recent Development
Table 92. Aurobindo Pharma Company Details
Table 93. Aurobindo Pharma Business Overview
Table 94. Aurobindo Pharma Antispasmodics Drugs Product
Table 95. Aurobindo Pharma Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 96. Aurobindo Pharma Recent Development
Table 97. Daiichi Sankyo Company Details
Table 98. Daiichi Sankyo Business Overview
Table 99. Daiichi Sankyo Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 100. Daiichi Sankyo Recent Development
Table 101. Fresenius Kabi Company Details
Table 102. Fresenius Kabi Business Overview
Table 103. Fresenius Kabi Antispasmodics Drugs Product
Table 104. Fresenius Kabi Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 105. Fresenius Kabi Recent Development
Table 106. Shanghai Fosun Pharmaceutical Company Details
Table 107. Shanghai Fosun Pharmaceutical Business Overview
Table 108. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Product
Table 109. Shanghai Fosun Pharmaceutical Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 110. Shanghai Fosun Pharmaceutical Recent Development
Table 111. SunGen Pharma Company Details
Table 112. SunGen Pharma Business Overview
Table 113. SunGen Pharma Antispasmodics Drugs Product
Table 114. SunGen Pharma Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million)
Table 115. SunGen Pharma Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antispasmodics Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. Others Features
Figure 5. Global Antispasmodics Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Special Clinic Case Studies
Figure 8. Home Care Case Studies
Figure 9. Others Case Studies
Figure 10. Antispasmodics Drugs Report Years Considered
Figure 11. Global Antispasmodics Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Antispasmodics Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antispasmodics Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Antispasmodics Drugs Market Share by Regions (2022-2027)
Figure 15. Global Antispasmodics Drugs Market Share by Players in 2020
Figure 16. Global Top Antispasmodics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antispasmodics Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Antispasmodics Drugs Revenue in 2020
Figure 18. Global Antispasmodics Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Antispasmodics Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Antispasmodics Drugs Market Share by Type (2016-2027)
Figure 22. North America Antispasmodics Drugs Market Share by Application (2016-2027)
Figure 23. North America Antispasmodics Drugs Market Share by Country (2016-2027)
Figure 24. United States Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antispasmodics Drugs Market Share by Type (2016-2027)
Figure 28. Europe Antispasmodics Drugs Market Share by Application (2016-2027)
Figure 29. Europe Antispasmodics Drugs Market Share by Country (2016-2027)
Figure 30. Germany Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antispasmodics Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Antispasmodics Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Antispasmodics Drugs Market Share by Region (2016-2027)
Figure 40. China Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antispasmodics Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Antispasmodics Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Antispasmodics Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antispasmodics Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Antispasmodics Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Antispasmodics Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 61. Lannett Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 63. Nexus Pharmaceuticals Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 64. Akorn Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 65. Aurobindo Pharma Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 66. Daiichi Sankyo Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 67. Fresenius Kabi Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 68. Shanghai Fosun Pharmaceutical Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 69. SunGen Pharma Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の鎮痙薬市場規模・現状・予測（2021年-2027年） It is a drug that suppresses muscle spasms, a type of antispasmodic used for smooth muscle contraction, especially in the tubular organs of the gastrointestinal tract. Market Analysis and Insights: Global Antispasmodics Drug Market The global Antispasmodics Drug market size is projected to reach US$…- 世界の掻痒治療薬市場規模・現状・予測（2021年-2027年） Transdermal drug delivery systems are the most preferred methods of delivering pruritus drugs. The majority of the pruritus drugs are available in semi-solid topical dosage forms, such as lotions, gels, and creams, which are easier to apply, are less painful, and provides faster action than other fo…
- 世界のがん支持療法薬剤市場規模・現状・予測（2021年-2027年） Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy. Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailore…
- 世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Beta-Lactam Drugs Market The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界のクリプトコックス症治療薬市場規模・現状・予測（2021年-2027年） Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, call…